Sputnik V, another vaccine against novel coronavirus got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA) in India, according to sources, mentioned news agency PTI.
Once approved, this will be the third COVID-19 vaccine in the country.The COVID-19 vaccine was developed by Gamaleya Research Institute and the Russian defence ministry.
COVID-19 vaccine offers lasting immunity from the virus, according to Russia health ministry. Named after named after the Soviet-era satellite, Sputnik V was approved in Russia in August 2020.The Russian Direct Investment Fund (RDIF) partnered with Dr Reddy's in September 2020 to conduct clinical trials of Sputnik V in India.